JP2008063281A - Liquid preparation composition - Google Patents

Liquid preparation composition Download PDF

Info

Publication number
JP2008063281A
JP2008063281A JP2006243468A JP2006243468A JP2008063281A JP 2008063281 A JP2008063281 A JP 2008063281A JP 2006243468 A JP2006243468 A JP 2006243468A JP 2006243468 A JP2006243468 A JP 2006243468A JP 2008063281 A JP2008063281 A JP 2008063281A
Authority
JP
Japan
Prior art keywords
caffeine
brain
yellow
test
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006243468A
Other languages
Japanese (ja)
Other versions
JP5010879B2 (en
Inventor
Masahiko Oe
昌彦 大江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Tokiwa Pharmaceutical Co Ltd
Original Assignee
Tokiwa Yakuhin Kogyo KK
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokiwa Yakuhin Kogyo KK, Noevir Co Ltd filed Critical Tokiwa Yakuhin Kogyo KK
Priority to JP2006243468A priority Critical patent/JP5010879B2/en
Publication of JP2008063281A publication Critical patent/JP2008063281A/en
Application granted granted Critical
Publication of JP5010879B2 publication Critical patent/JP5010879B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide a liquid preparation composition leading the consciousness level of a brain in a human to a relaxed state, and bringing the effective improvement of calculation performance. <P>SOLUTION: This oral composition is provided by containing caffeine and a root stem extract derived from Polygonatum falcatum as active ingredients. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、脳の意識レベルをリラックス状態に導くことにより、ヒトの演算能力の向上効果をもたらす液剤組成物に関する。
The present invention relates to a liquid composition that brings about an effect of improving human computing ability by leading a brain consciousness level to a relaxed state.

カフェインは、茶葉中に含まれる中枢性興奮作用を有する成分として知られ、旧来より、覚醒効果を期待した各種飲料が発売されている。近年では、その中枢性作用に着目し、カルボニックアンヒドラーゼ活性化因子との併用や(特許文献1参照)、茶葉中に含まれる成分テアニンとの併用(特許文献2参照)によって、ヒトの認知能力や注意集中力を高める技術が開示されてきた。また、同様に茶葉中に含まれる成分エピカテキンとの組合わせでは、精神疲労に対する緩和効果をもたらす技術が開示されている(特許文献3参照)。そして、カフェインと茶葉成分を組合せた上で、さらに、特定のアミノ酸を併用することにより、精神疲労の緩和と集中力の維持増強がもたらされることが明らかにされている(特許文献4参照)。しかし、これらの技術は、疲労状態にある精神機能を緩和・軽減することで、認知能力や注意集中力の回復改善効果を示すに留まり、数学的演算行為など、健常人におけるより高度な思考活動に対する能力向上効果を示すまでには至っていない。   Caffeine is known as a component having a central excitatory action contained in tea leaves, and various drinks that have been expected to have an arousal effect have been on the market for a long time. In recent years, focusing on its central action, human cognition has been achieved through the combined use with carbonic anhydrase activator (see Patent Document 1) and with theanine component contained in tea leaves (see Patent Document 2). Techniques have been disclosed to increase ability and attention concentration. Similarly, in combination with the component epicatechin contained in tea leaves, a technique for providing a relaxation effect on mental fatigue has been disclosed (see Patent Document 3). And after combining caffeine and a tea leaf component, it is clarified that the combined use of a specific amino acid brings about relaxation of mental fatigue and maintenance of concentration (see Patent Document 4). . However, these technologies only improve recovery of cognitive ability and attention concentration by relieving and reducing mental functions in a fatigued state, and more advanced thinking activities such as mathematical operations in healthy people. It has not yet been shown to improve the ability to

特表2005−526065Special table 2005-526065 特開2006−153898JP 2006-153898 A 特開2002−80363JP2002-80363 特開2002−322063JP 2002-322063 A

本発明者らは、数学的演算行為など、脳における高度な思考活動の能力向上を図ることを目的とした。すなわち、従来のカフェインと茶葉成分の組合わせによって導かれる疲労状態における精神疲労の回復改善効果だけでは不十分であると考えた。本発明は、健常人において、より積極的に脳意識レベルをリラックス状態に導き、単なる認知能力や注意集中力の回復改善に留まらない、演算能力の向上効果に優れた液剤組成物を提供することを目的とする。
The present inventors have aimed to improve the ability of advanced thinking activities in the brain, such as mathematical operations. That is, it was considered that the mental fatigue recovery improvement effect in a fatigue state derived from a combination of conventional caffeine and tea leaf components is not sufficient. The present invention provides a liquid composition excellent in the effect of improving the computing ability, not only improving the recovery of cognitive ability and attention concentration, but also leading the brain consciousness level to a relaxed state more actively in a healthy person. With the goal.

本発明者らは、健常人において脳活動をリラックス状態に導き、より高度な思考活動の能力を向上せしめる液剤組成物の研究を鋭意進めてきた。その結果、カフェインにユリ科植物由来の黄精抽出物を加えることにより、演算能力を効果的に向上せしめる液剤組成物を見出し、本発明を完成するに至った。   The inventors of the present invention have been diligently researching a liquid composition that leads brain activity to a relaxed state in a healthy person and improves the ability of more advanced thinking activities. As a result, by adding a yellow extract derived from a lily family plant to caffeine, the present inventors have found a liquid composition that can effectively improve the computing ability, and have completed the present invention.

本発明は、カフェインおよびユリ科植物ナルコユリ由来の黄精抽出物を合わせて含有することを特徴とする液剤組成物の提供に関する。
The present invention relates to the provision of a liquid composition comprising a combination of caffeine and a yellow extract derived from a lily family plant Narcoli.

本発明によれば、液剤組成物において、カフェインにユリ科植物ナルコユリ由来の黄精抽出物を配合することにより、健常人の脳意識レベルをリラックス状態に導き、あわせて演算能力の向上を図ることが可能となる。
According to the present invention, in the liquid composition, the brain consciousness level of a healthy person is brought into a relaxed state by combining caffeine with a yellow spirit extract derived from the lily family plant Narcoli, and at the same time, the computing ability is improved. Is possible.

本発明に用いられる黄精抽出物の出発原料となる黄精は、ユリ科(Liliaceae)の植物ナルコユリ(Polygonatumalcatum)の根茎であり、おもに中国本土の長江流域以北の諸省または自治区(黒龍江、吉林、遼寧、河北、山東、江蘇、河南、山西、陝西、内蒙古)を産地とする。 Polygonati Rhizoma as a starting material of Polygonati Rhizoma extract used in the present invention is the rhizome of a plant Narukoyuri the Liliaceae (Liliaceae) (Polygonatum f alcatum) , mainly Chinese mainland various Ministry or autonomous regions of Yangtze basin north (Heilongjiang , Jilin, Liaoning, Hebei, Shandong, Jiangsu, Henan, Shanxi, Shaanxi, Inner Mongolia).

黄精は、乾燥粉砕したものをそのまま使用することができるが、溶媒等を用いて抽出した抽出物を用いることもできる。抽出の際は、生のまま用いてもよいが、抽出効率を考えると、細切、乾燥、粉砕等の処理を行った後に抽出を行うことが望ましい。抽出は、抽出溶媒に浸漬する方法や超臨界流体等を用いた抽出方法など一般的な方法で行うことができる。抽出温度としては、5℃程度から抽出溶媒の沸点以下の温度とするのが好ましい。抽出時間は抽出溶媒の種類や抽出温度によっても異なるが、1時間〜14日間程度とするのが好ましい。   As for yellow spirit, dried and pulverized one can be used as it is, but an extract extracted with a solvent or the like can also be used. At the time of extraction, it may be used as it is, but considering the extraction efficiency, it is desirable to perform the extraction after performing processing such as shredding, drying, and pulverization. The extraction can be performed by a general method such as a method of immersing in an extraction solvent or an extraction method using a supercritical fluid or the like. The extraction temperature is preferably about 5 ° C. to the boiling point of the extraction solvent. The extraction time varies depending on the type of extraction solvent and the extraction temperature, but is preferably about 1 hour to 14 days.

抽出溶媒としては、例えば、水、メタノール、エタノールのごとき低級アルコール、グリセリン、プロピレングリコール、1,3−ブチレングリコールなどの多価アルコール、酢酸エチル等のエステル類、アセトン等のケトン類、などの有機溶媒またはそれらの混合物を用いることができる。   Examples of the extraction solvent include organic compounds such as water, methanol, ethanol and other lower alcohols, glycerin, propylene glycol, polyhydric alcohols such as 1,3-butylene glycol, esters such as ethyl acetate, and ketones such as acetone. Solvents or mixtures thereof can be used.

得られた抽出物は、そのままでも用いることができるが、濃縮、乾固したものを水や溶媒に再度溶解したり、あるいはこれらの作用を損なわない範囲で脱色、脱臭、脱塩等の精製処理を行ったり、カラムクロマトグラフィーによる分画処理を行った後に用いてもよい。また、保存のため、精製処理の後凍結乾燥し、使用時に溶媒に溶解して用いることもできる。   The obtained extract can be used as it is, but the concentrated and dried product is dissolved again in water or a solvent, or purification treatment such as decolorization, deodorization, and desalting is performed without impairing these actions. Or after fractionation by column chromatography. For storage, it can be freeze-dried after purification and dissolved in a solvent when used.

本発明で用いる黄精抽出物の配合量は、液剤組成物全体の0.1w/w%以上であれば良いが、10w/w%を超える配合量では製剤時に気泡が発生するなどの弊害が生じやすくなる。よって、本発明で用いる黄精抽出物の配合量としてより好ましくは、0.1w/w%〜10w/w%が良い。   The blending amount of the yellow extract used in the present invention may be 0.1 w / w% or more of the whole liquid composition, but if the blending amount exceeds 10 w / w%, problems such as generation of bubbles at the time of preparation occur. It becomes easy. Therefore, the blending amount of the yellow extract used in the present invention is more preferably 0.1 w / w% to 10 w / w%.

本発明は、さらにその他生薬を配合することにより、さらなる効果を発揮することができる。   The present invention can exhibit further effects by further blending other herbal medicines.

本発明に用いることのできる生薬とは、好ましくは、菊花、高麗人参、茶、ガラナからなる群より選ばれる1種または2種以上である。   The herbal medicine that can be used in the present invention is preferably one or more selected from the group consisting of chrysanthemum, ginseng, tea, and guarana.

次に、本発明において用いるカフェインとは、医薬品用原料として市販されているものの他、飲食品用途として市販されている茶葉(Thea sinensis)やガラナ(Paullinia cupana)など、カフェインを多く含むことが知られている植物の抽出物を任意に用いることができる。 Next, the caffeine used in the present invention contains a lot of caffeine such as tea leaves ( Thea sinensis ) and guarana ( Paulinia cupana ) which are marketed as food and drink products, in addition to those marketed as raw materials for pharmaceuticals. An extract of a plant known in the art can be arbitrarily used.

本発明の液剤組成物には、通常液剤に用いることが可能な成分、例えば、ビタミン類、アミノ酸類、有機酸類、生薬、甘味料、香料、保存剤などの他、栄養強化成分、滋養強壮成分などを適時選択して配合することができ、液剤製造の常法により製造することができる。   In the liquid composition of the present invention, ingredients that can be used in normal liquid preparations, for example, vitamins, amino acids, organic acids, herbal medicines, sweeteners, fragrances, preservatives, etc., nutrition enhancing ingredients, nourishing tonic ingredients Etc. can be selected and blended in a timely manner, and can be produced by a conventional method for producing a liquid preparation.

以下に本発明の組成物のリラックス効果ならびに演算能力向上効果を、以下の調製例に示した飲料組成物ならびに実施例により確認した。なお、本発明はこれら実施例により何ら制限されるものではない
Below, the relaxation effect of the composition of this invention and the calculation capability improvement effect were confirmed by the drink composition and the Example which were shown to the following preparation examples. In addition, this invention is not restrict | limited at all by these Examples.

調製例:飲料組成物
被験飲料(各50mL)を表1に示す処方に従って調製した。各飲料はそれぞれ1試飲あたり、カフェイン150mg(比較例1)、黄精抽出物100mg(比較例2)、カフェイン150mgおよび黄精抽出物100mgを含有する(試験例1)。さらに、プラセボとして、カフェインと黄精抽出物のいずれをも含まないものを調製した(比較例3)。
Preparation Example: A beverage composition test beverage (each 50 mL) was prepared according to the formulation shown in Table 1. Each beverage contains 150 mg of caffeine (Comparative Example 1), 100 mg of yellow extract (Comparative Example 2), 150 mg of caffeine and 100 mg of yellow extract (Test Example 1). Furthermore, a placebo containing neither caffeine nor yellow extract was prepared (Comparative Example 3).

Figure 2008063281
Figure 2008063281

被験飲料ごとに、リラックス効果および演算能力向上効果についてテストした。   Each test beverage was tested for relaxation effect and computational performance improvement effect.

実施例1:脳波の計測
大脳の働きにともなって発生する脳波は、周波数と振幅によって4つのタイプに分類され、各脳波の出現頻度をもって脳の意識状態を計り知ることができる。周波数8〜13ヘルツのα波はリラックスや瞑想の意識状態を、周波数14〜30ヘルツのβ波は緊張状態を、周波数0.5〜3ヘルツのγ波は熟睡などの無意識状態を、周波数4〜7ヘルツのθ波はまどろみの意識状態を示す指標とされている。
Example 1: Measurement of brain waves The brain waves generated with the action of the cerebrum are classified into four types according to the frequency and amplitude, and the state of consciousness of the brain can be measured and known from the appearance frequency of each brain wave. An α wave with a frequency of 8 to 13 Hz indicates a conscious state of relaxation or meditation, a β wave with a frequency of 14 to 30 Hz indicates a tension state, a γ wave with a frequency of 0.5 to 3 Hz indicates an unconscious state such as deep sleep, and the frequency 4 A θ wave of ˜7 hertz is regarded as an index indicating a state of consciousness of stagnation.

テストは簡易脳波測定装置マインドナビ(日立超LSIシステムズ社製)を用いた。被験者の安静状態を保てる環境下にて、各飲料の飲用前後のα波出現頻度を記録し、その変化量をもって、飲用によるリラックス状態への誘導効果を評価した。結果を図1に示す。   For the test, a simple electroencephalogram measuring device Mind Navi (manufactured by Hitachi VLSI Systems) was used. In an environment where the subject was able to maintain a resting state, the frequency of appearance of α waves before and after the drinking of each beverage was recorded, and the amount of change was used to evaluate the effect of inducing relaxation by drinking. The results are shown in FIG.

図1に示したように、プラセボ(比較例3)と黄精抽出物のみを含む被験飲料(比較例2)では、飲用によるα波の出現頻度に明らかな変化は認められず、黄精抽出物のみでは、α波の増加をもたらさないことを示した。一方、カフェインを含む被験飲料(試験例1、比較例1)では飲用後のα波の増加、すなわち、脳意識レベルのリラックス状態への誘導効果が見られたが、とりわけカフェインと黄精抽出物の双方を含む被験飲料(試験例1)では当該効果の発現が顕著であり、黄精抽出物がカフェインのα波増強効果をよりいっそう強化すること示した。
As shown in FIG. 1, in the test beverage (Comparative Example 2) containing only the placebo (Comparative Example 3) and the yellow extract, no obvious change was observed in the frequency of appearance of α waves due to drinking, only the yellow extract Then, it showed that it does not bring about the increase of alpha wave. On the other hand, test drinks containing caffeine (Test Example 1 and Comparative Example 1) showed an increase in alpha waves after drinking, that is, an induction effect on a relaxed state of brain consciousness. In the test beverage containing both of the products (Test Example 1), the expression of the effect was remarkable, and it was shown that the extract of yellow spirit further enhances the α-wave enhancing effect of caffeine.

実施例2:演算能力の評価
演算能力は、一定時間内における百マス計算によって評価した。百マス計算とは、図2に示したように、縦と横に0〜9の10個ずつの数字が並べられた方眼様シートを用いて、10列×10行の足し算演算を行い、その結果を所定のマスに記入するというものである。なお、数字の並びは各シートごとに無作為に変化させたものを用いた。
Example 2: Evaluation of computing ability The computing ability was evaluated by calculating one hundred squares within a certain period of time. As shown in FIG. 2, the hundred-mass calculation is performed by adding 10 columns × 10 rows using a grid-like sheet in which 10 numbers of 0 to 9 are arranged vertically and horizontally. The result is entered in a predetermined square. In addition, the arrangement of numbers was changed randomly for each sheet.

被験者に被験飲料の飲用前後の各10分間に、可能な限りの百マス計算を行ってもらい、その回答数と正答率をもって、飲用による演算能力の向上効果を評価した。結果を図3と図4に示す。   The subject was asked to perform as many hundreds of calculations as possible during each 10 minutes before and after drinking the test beverage, and the improvement effect of the computing ability by drinking was evaluated with the number of answers and the correct answer rate. The results are shown in FIGS.

図3に示したように、プラセボ(比較例3)と黄精抽出物のみを含む被験飲料(比較例2)では、飲用による回答数の増加は認められず、黄精抽出物のみでは、回答数を増加させる作用がないことを示した。一方、カフェインを含む被験飲料(試験例1、比較例1)では、飲用による回答数の増加が認められた。とりわけカフェインと黄精抽出物の双方を含む被験飲料(試験例1)では、より顕著な回答数の増加が認められ、黄精抽出物がカフェインの飲用による回答数の増加作用をよりいっそう強化すること示した。   As shown in FIG. 3, in the test beverage (Comparative Example 2) containing only the placebo (Comparative Example 3) and the yellow extract, the increase in the number of responses due to drinking was not observed. It was shown that there was no effect to increase. On the other hand, in the test beverages containing caffeine (Test Example 1, Comparative Example 1), an increase in the number of responses due to drinking was observed. In particular, in the test drink containing both caffeine and yellow extract (Test Example 1), a more remarkable increase in the number of responses was observed, and the yellow extract further strengthened the effect of increasing the number of responses due to drinking caffeine. I showed that.

図4は正答率を示したものであるが、いずれの被験飲料の飲用でも正答率の低下は認められていない。すなわち、前記カフェインを含む被験飲料の飲用による回答数の増加は、単なる公知のカフェインの中枢性興奮作用によって誘発された、粗雑な回答数の増加ではなく、計算精度を損ねることなく、回答数を増したものであることを明らかにした。   FIG. 4 shows the correct answer rate, but no decrease in the correct answer rate is observed in any of the test beverages. That is, the increase in the number of responses by drinking the test beverage containing caffeine is not simply an increase in the number of rough responses induced by the known central excitatory action of caffeine, but without compromising calculation accuracy. Clarified that the number increased.

以上、カフェインの飲用は、脳の意識レベルを高度な思考活動を行う上での理想的なリラックス状態へと誘導し、あわせて効果的な演算能力の向上効果をもたらすが、その作用は、黄精抽出物との併用によってより、いっそう増強されることを見い出した。   As described above, drinking caffeine induces the brain's level of consciousness to an ideal relaxed state for advanced thinking activities, and at the same time, brings about an effect of improving effective computing ability. It was found that it was further enhanced by combined use with yellow extract.

本発明の経口用組成物を用いれば、優れた演算能力の向上効果を有する製剤を得ることができる。また、本発明の経口用組成物は、副作用等の心配がなく、日常的に連用可能な清涼飲料水やドリンク剤等として用いることができ、医薬品、医薬部外品、栄養補助食品、健康食品として利用することができる。
If the composition for oral use of this invention is used, the formulation which has the improvement effect of the outstanding computing ability can be obtained. Further, the oral composition of the present invention has no worries about side effects and can be used as a soft drink or drink that can be used on a daily basis, and can be used as a pharmaceutical, quasi-drug, dietary supplement, health food. Can be used as

実施例1に示した脳意識レベルのリラックス状態への誘導を示した図である。It is the figure which showed the induction | guidance | derivation to the relaxation state of the brain consciousness level shown in Example 1. FIG. 実施例2で用いた百マス計算シートHundred squares calculation sheet used in Example 2 実施例2で示した回答数の増加を示した図である。It is the figure which showed the increase in the number of answers shown in Example 2. FIG. 実施例2で示した正答率への影響の有無を示した図である。It is the figure which showed the presence or absence of the influence on the correct answer rate shown in Example 2. FIG.

Claims (3)

カフェインおよびユリ科植物ナルコユリ由来の黄精抽出物を含有してなる液剤組成物。 A liquid composition comprising a yellow extract derived from caffeine and a lily family plant Narcoli. カフェインおよびユリ科植物ナルコユリ由来の黄精抽出物を含有してなるα波増強剤。 An α wave enhancer comprising a yellow extract derived from caffeine and a lily family plant Narcoli. カフェインおよびユリ科植物ナルコユリ由来の黄精抽出物を含有してなる演算能力向上剤。 A computing capacity improver comprising a yellow spirit extract derived from caffeine and a lily family plant Narcoli.
JP2006243468A 2006-09-07 2006-09-07 Liquid composition Active JP5010879B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006243468A JP5010879B2 (en) 2006-09-07 2006-09-07 Liquid composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006243468A JP5010879B2 (en) 2006-09-07 2006-09-07 Liquid composition

Publications (2)

Publication Number Publication Date
JP2008063281A true JP2008063281A (en) 2008-03-21
JP5010879B2 JP5010879B2 (en) 2012-08-29

Family

ID=39286285

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006243468A Active JP5010879B2 (en) 2006-09-07 2006-09-07 Liquid composition

Country Status (1)

Country Link
JP (1) JP5010879B2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513509A (en) * 1997-08-11 2001-09-04 エル・ヴェ・エム・アッシュ ルシェルシュ Use of Narcoli Lily Extract to Promote Dermal Elastin Synthesis
JP2005176691A (en) * 2003-12-18 2005-07-07 Asahi Breweries Ltd Nutritionally tonic alcoholic drink
JP2006273809A (en) * 2005-03-30 2006-10-12 Naris Cosmetics Co Ltd Vegetable trypsin inhibitor
JP2007153816A (en) * 2005-12-06 2007-06-21 Taisho Pharmaceut Co Ltd Fatigue relieving agent composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513509A (en) * 1997-08-11 2001-09-04 エル・ヴェ・エム・アッシュ ルシェルシュ Use of Narcoli Lily Extract to Promote Dermal Elastin Synthesis
JP2005176691A (en) * 2003-12-18 2005-07-07 Asahi Breweries Ltd Nutritionally tonic alcoholic drink
JP2006273809A (en) * 2005-03-30 2006-10-12 Naris Cosmetics Co Ltd Vegetable trypsin inhibitor
JP2007153816A (en) * 2005-12-06 2007-06-21 Taisho Pharmaceut Co Ltd Fatigue relieving agent composition

Also Published As

Publication number Publication date
JP5010879B2 (en) 2012-08-29

Similar Documents

Publication Publication Date Title
Dietz et al. An intervention study on the effect of matcha tea, in drink and snack bar formats, on mood and cognitive performance
TWI500391B (en) Composition for reliving and preventing hangover and beverage comprising composition
CN102293430A (en) Beverage with functions of antioxidation and immunity enhancing, and preparation method thereof
KR101827326B1 (en) Chinese medical composition for curing a hangover
JP2016538328A5 (en)
CN104815100A (en) Composition with effects of refreshing and restoring consciousness and application thereof
CN102813255B (en) Functional health drink and preparation method thereof
JP5010879B2 (en) Liquid composition
CN106176495B (en) A kind of carefree shower cream and preparation method thereof
CN106266515B (en) Join Siberian cocklebur grass composition, ginseng Siberian cocklebur grass drink and preparation method
CN114766565A (en) Physical fatigue relieving tea beverage and preparation method thereof
JP2005239659A (en) Precursor lipocyte differentiation inhibitor
CN110547381A (en) Preparation method of papaya enzyme compound beverage
JP2011168523A (en) Agent for alleviating symptom attributable to premenstrual syndrome and food and beverage containing the same
JP7383281B2 (en) Oral composition and functional food for improving learning ability of young people
CN103070261B (en) Formula of red bean tea powder and production method
JP2006348001A (en) Poor circulation-improving agent and functional food
CN101569691B (en) Refreshing pill and preparation method thereof
CN112516258B (en) Composition, preparation method and application thereof
CN107467324A (en) A kind of active component containing American cockroach has the coffee of anti-inflammation detumescence effect
RU2425583C1 (en) &#34;lofantovy&#34; tea beverage
CN107712183A (en) One group of U.S. face of enriching blood supports kidney rose-tee prescription
CN105875961A (en) Lung moistening and phlegm eliminating healthy tea beverage
CN105232435A (en) Rosemary essential oil bath salt and preparation method
CN106605879A (en) Rosa roxburghii tratt fruit jam and preparation method thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090528

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20090528

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20110927

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120214

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120403

RD13 Notification of appointment of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7433

Effective date: 20120403

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20120403

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120522

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120604

R150 Certificate of patent or registration of utility model

Ref document number: 5010879

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150608

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250